Mr. Uddin has been the senior financial analyst at Waverley Pharma since August 2019.  Previously, he worked at Ernst & Young as a senior accountant in assurance services.  Mr. Uddin has significant experience working with life science companies in both Canada and the United States and spent time in both Houston, Texas and San Francisco, California working with clients.  He has a Bachelor of Commerce (Hons.) degree from the University of Manitoba and is a Chartered Professional Accountant.